$484 Million is the total value of ARMISTICE CAPITAL, LLC's 47 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $66,007,000 | – | 280,000 | +100.0% | 13.63% | – |
| WFM | New | WHOLE FOODS MKT INCcall | $20,804,000 | – | 700,000 | +100.0% | 4.30% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $15,500,000 | – | 40,000 | +100.0% | 3.20% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $12,851,000 | – | 106,000 | +100.0% | 2.65% | – |
| FTDCQ | New | FTD COS INC | $10,070,000 | – | 500,000 | +100.0% | 2.08% | – |
| VSTO | New | VISTA OUTDOOR INC | $9,266,000 | – | 450,000 | +100.0% | 1.91% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $9,254,000 | – | 956,000 | +100.0% | 1.91% | – |
| SEAS | New | SEAWORLD ENTMT INC | $8,770,000 | – | 480,000 | +100.0% | 1.81% | – |
| SBBP | New | STRONGBRIDGE BIOPHARMA PLC | $7,790,000 | – | 1,640,000 | +100.0% | 1.61% | – |
| BBY | New | BEST BUY INC | $7,373,000 | – | 150,000 | +100.0% | 1.52% | – |
| DECK | New | DECKERS OUTDOOR CORPcall | $5,973,000 | – | 100,000 | +100.0% | 1.23% | – |
| ANF | New | ABERCROMBIE & FITCH COcl a | $5,369,000 | – | 450,000 | +100.0% | 1.11% | – |
| DKS | New | DICKS SPORTING GOODS INC | $4,866,000 | – | 100,000 | +100.0% | 1.00% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $2,832,000 | – | 4,800,000 | +100.0% | 0.58% | – |
| WSM | New | WILLIAMS SONOMA INC | $2,788,000 | – | 52,000 | +100.0% | 0.58% | – |
| TLRDQ | New | TAILORED BRANDS INCcall | $2,390,000 | – | 160,000 | +100.0% | 0.49% | – |
| DYNT | New | DYNATRONICS CORP | $1,425,000 | – | 500,000 | +100.0% | 0.29% | – |
| ATEC | New | ALPHATEC HOLDINGS INC | $1,264,000 | – | 542,414 | +100.0% | 0.26% | – |
| PDLI | New | PDL BIOPHARMA INC | $1,135,000 | – | 500,000 | +100.0% | 0.23% | – |
| ZFGN | New | ZAFGEN INC | $522,000 | – | 112,000 | +100.0% | 0.11% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.